1 unknown. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Primary Immunodeficiency: new trials by email Literature Review of Primary Immunodeficiency trials Research Report on Primary Immunodeficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ASIS for GAMMAGARD in Primary Immunodeficiency Gadolinium For abdomen, Gadolinium For lower back, Efficacy of Gammagard subcutaneously at Week 12 - Primary Immunodeficiency | Phase 1 / Phase 2 | Unknown | ASIS Corporation | 60 | 2016-01-01 | 2015-06-24 |
Primary Immunodeficiency Diseases (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1)
Gadolinium (1) · Gadolinium DTPA (1) · Immunoglobulins, Intravenous (1)
ASIS Corporation (1)
United States (1)
Hanh Nguyen, MD (1) · Li Nguyen, MD (1) · Thanh Phung, MD (1)